| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 564,1 k € | -3.9% | 586,8 k € | -10.9% | 658,3 k € | +1.2% | 650,2 k € | +65.7% | 392,4 k € | -8.7% | 429,8 k € | +276.7% | 114,1 k € | -73.4% | 428,6 k € | +6.6% | 402,0 k € | -6.9% | 431,9 k € | +7.7% | 401,1 k € | +1.9% | 393,4 k € | +14.4% | 343,8 k € | -32.0% | 505,4 k € | -22.6% | 653,0 k € | +66.2% | 393,0 k € | +31.3% | 299,3 k € | +16.2% | 257,4 k € | |
| EBITDA | 562,7 k € | -3.8% | 585,0 k € | -11.0% | 657,0 k € | +1.3% | 648,4 k € | +66.0% | 390,5 k € | -8.9% | 428,7 k € | +279.1% | 113,1 k € | -73.5% | 425,9 k € | +6.4% | 400,5 k € | -6.9% | 430,4 k € | +7.7% | 399,6 k € | +2.3% | 390,4 k € | +14.5% | 341,1 k € | -32.2% | 503,4 k € | -22.7% | 651,5 k € | +66.4% | 391,5 k € | +31.9% | 296,8 k € | +15.6% | 256,8 k € | |
| Operating profit | 539,7 k € | -6.8% | 579,2 k € | -8.9% | 635,5 k € | +1.4% | 626,9 k € | +70.2% | 368,3 k € | -9.6% | 407,4 k € | +334.4% | 93,8 k € | -77.4% | 414,7 k € | +7.2% | 386,7 k € | -7.3% | 417,3 k € | +8.0% | 386,5 k € | +4.7% | 369,1 k € | +13.9% | 324,1 k € | -34.3% | 493,1 k € | -22.7% | 637,7 k € | +68.9% | 377,6 k € | +31.3% | 287,6 k € | +18.0% | 243,7 k € | |
| Profit/loss | 388,9 k € | -2.5% | 399,1 k € | -8.7% | 437,2 k € | +6.7% | 409,6 k € | +65.5% | 247,5 k € | -5.7% | 262,6 k € | +302.9% | 65,2 k € | -75.1% | 261,4 k € | +15.1% | 227,2 k € | +10.4% | 205,7 k € | -9.2% | 226,5 k € | -4.2% | 236,5 k € | +15.4% | 204,9 k € | -40.3% | 343,5 k € | -19.6% | 427,3 k € | +66.9% | 256,0 k € | +30.0% | 196,9 k € | +22.0% | 161,3 k € | |
| Equity | 2,3 M € | +16.0% | 2,0 M € | +19.1% | 1,7 M € | +14.0% | 1,5 M € | -13.9% | 1,7 M € | +0.1% | 1,7 M € | +17.9% | 1,5 M € | +4.7% | 1,4 M € | +23.0% | 1,1 M € | +24.9% | 911,0 k € | +29.2% | 705,2 k € | +47.3% | 478,7 k € | +97.6% | 242,2 k € | +626.3% | 33,4 k € | -95.8% | 788,8 k € | +25.9% | 626,6 k € | +69.1% | 370,5 k € | +113.3% | 173,7 k € | |
| Total assets | 2,4 M € | +14.8% | 2,1 M € | +16.1% | 1,8 M € | +9.5% | 1,6 M € | -21.7% | 2,1 M € | +0.5% | 2,1 M € | +16.2% | 1,8 M € | +3.0% | 1,7 M € | +18.3% | 1,5 M € | +14.6% | 1,3 M € | +19.5% | 1,1 M € | +25.5% | 844,6 k € | +36.9% | 617,1 k € | +100.5% | 307,9 k € | -72.0% | 1,1 M € | +62.4% | 676,5 k € | +22.6% | 551,8 k € | +114.9% | 256,7 k € | |
| Cash | 739,9 k € | -51.4% | 1,5 M € | +15.3% | 1,3 M € | +18.4% | 1,1 M € | -41.4% | 1,9 M € | +3.0% | 1,8 M € | +19.0% | 1,6 M € | -2.9% | 1,6 M € | +20.8% | 1,3 M € | +19.0% | 1,1 M € | +24.9% | 889,9 k € | +39.1% | 639,8 k € | +65.1% | 387,4 k € | +174.7% | 141,1 k € | -86.1% | 1,0 M € | +71.5% | 593,2 k € | +1051.7% | 51,5 k € | -47.7% | 98,5 k € | |
| Debts | 11,8 k € | -62.7% | 31,8 k € | -53.7% | 68,6 k € | -44.2% | 122,9 k € | -62.6% | 328,7 k € | +4.0% | 316,1 k € | +8.1% | 292,5 k € | -4.1% | 305,0 k € | +1.0% | 302,1 k € | -12.0% | 343,4 k € | +0.4% | 342,1 k € | -3.0% | 352,5 k € | -2.7% | 362,2 k € | +36.1% | 266,1 k € | -13.8% | 308,8 k € | +533.4% | 48,8 k € | -73.0% | 180,3 k € | +117.2% | 83,0 k € | |
Private limited company · Kortrijk · incorporated on 19/03/2007
Private limited company profitable and well capitalised. Cash position declining (-51.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DOKTER MICHAEL BOUDEWIJNS is a Private limited company incorporated in 2007. Its main activity is: Other human health activities. Its registered office is in Kortrijk.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette